Moody National Bank Trust Division Reduces Holdings in Intuitive Surgical, Inc. $ISRG

Moody National Bank Trust Division reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 31.9% during the 4th quarter, Holdings Channel.com reports. The fund owned 4,089 shares of the medical equipment provider’s stock after selling 1,918 shares during the quarter. Moody National Bank Trust Division’s holdings in Intuitive Surgical were worth $2,316,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in ISRG. Schaper Benz & Wise Investment Counsel Inc. WI increased its position in Intuitive Surgical by 1.9% during the fourth quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 36,894 shares of the medical equipment provider’s stock worth $20,895,000 after buying an additional 684 shares during the period. Eastover Investment Advisors LLC increased its position in Intuitive Surgical by 2.0% during the 4th quarter. Eastover Investment Advisors LLC now owns 12,764 shares of the medical equipment provider’s stock worth $7,229,000 after purchasing an additional 252 shares during the period. Brucke Financial Inc. purchased a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $204,000. Spinnaker Investment Group LLC raised its stake in shares of Intuitive Surgical by 6.4% during the 4th quarter. Spinnaker Investment Group LLC now owns 552 shares of the medical equipment provider’s stock worth $313,000 after buying an additional 33 shares in the last quarter. Finally, Howard Financial Services LTD. lifted its holdings in shares of Intuitive Surgical by 18.9% in the 4th quarter. Howard Financial Services LTD. now owns 973 shares of the medical equipment provider’s stock valued at $551,000 after buying an additional 155 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Myriam Curet sold 105 shares of Intuitive Surgical stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total value of $51,864.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, VP Fredrik Widman sold 133 shares of the stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the transaction, the vice president owned 660 shares in the company, valued at $326,673.60. This trade represents a 16.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 32,943 shares of company stock worth $17,279,568 over the last ninety days. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $471.91 on Wednesday. The firm has a market cap of $167.59 billion, a PE ratio of 59.81, a P/E/G ratio of 3.69 and a beta of 1.66. The firm has a 50 day simple moving average of $499.14 and a 200-day simple moving average of $513.66. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping the consensus estimate of $2.27 by $0.26. The firm had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same period in the previous year, the company earned $2.21 EPS. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive is buying the da Vinci and Ion distribution business in Southern Europe to take direct control of sales and service, aiming to improve system availability, customer support and hospital access—moves that can boost recurring service revenue and reduce third‑party distribution costs in a strategic region. Read More.
• Positive Sentiment: Analysts and outlets continue to highlight ISRG’s market leadership versus peers (e.g., Stryker), emphasizing stronger growth and recurring‑revenue characteristics—supportive for long‑term premium valuation if execution and procedure growth persist. Read More.
• Neutral Sentiment: Q4 margins contracted amid tariff pressure but remained high (reported ~37%), with the company pointing to cost efficiencies and recurring revenue strength that partially offset headwinds—this is a mixed signal: profitability is intact but external cost pressures could persist. Read More.
• Neutral Sentiment: Coverage pieces and “trending stock” writeups (Zacks/Yahoo) have increased attention on ISRG—greater retail/institutional focus can amplify moves but doesn’t by itself change fundamentals. Read More.
• Negative Sentiment: Shares have moved lower in recent sessions (closed around $471.91 in the latest session reported), reflecting investor caution about execution, tariff/margin risks and elevated valuation (P/E ~60). Short‑term price action is negative. Read More.
• Negative Sentiment: Data feeds flagged a reported rise in short interest for March, though the published values appear inconsistent—if short interest is rising it could add selling pressure; treat current short‑interest reporting with caution. Read More.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Royal Bank Of Canada upped their price objective on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. The Goldman Sachs Group restated a “buy” rating and set a $714.00 target price on shares of Intuitive Surgical in a research report on Friday, January 9th. Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. Argus cut their price objective on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Finally, BTIG Research reiterated a “buy” rating and set a $616.00 target price on shares of Intuitive Surgical in a report on Friday, January 23rd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $614.95.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.